Investors Want Abbott To Explain Delay In Alere Deal
Abbott Laboratories must turn over documents related to its motive for balking at and then renegotiating its $5.3 billion purchase of Alere Inc., Alere investors said Thursday in Massachusetts federal court,...To view the full article, register now.
Already a subscriber? Click here to view full article